Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 5, p. 523, doi. 10.1111/apt.14893

By:

• Joosse, M. E.;
• Aardoom, M. A.;
• Kemos, P.;
• Turner, D.;
• Wilson, D. C.;
• Koletzko, S.;
• Martin‐de‐Carpi, J.;
• Fagerberg, U. L.;
• Spray, C.;
• Tzivinikos, C.;
• Sladek, M.;
• Shaoul, R.;
• Roma‐Giannikou, E.;
• Bronsky, J.;
• Serban, D. E.;
• Ruemmele, F. M.;
• Garnier‐Lengline, H.;
• Veres, G.;
• Hojsak, I.;
• Kolho, K. L.

Publication type:

Article